featured

Highlighting innovation

FROM THE BLOG

Our insights

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Senior Care
Investor Insight

What’s hot in biomaterials, according to investors

To find out investor’s thoughts on the biomaterials sector, we spoke to three members of our BioCapital Network; Sarah Jones - Principal at Zero Carbon Capital, Elisabetta Sakiotis - Analyst at Rockstart, and Josh Armistead-Wood - Senior Associate at Sustainable Ventures.

Author

June 27, 2024

Senior Care
Startup Spotlight

BoobyBiome: Pioneering Infant Health Innovation.

BoobyBiome, a start-up innovating the realm of infant health, is spearheading efforts to redefine neonatal care through a deep understanding of the gut microbiome. Founded by Lydia, Sioned, and Tara, they are dedicated to leveraging cutting-edge science to optimise infant health outcomes, particularly focusing on premature infants.

Author

Joanna Myślińska

June 19, 2024

Senior Care
Sector Insight

Biomaterials: Are they the answer to our sustainability issues?

Whilst biomaterials are entering an exciting era within regenerative medicine, it has become clear the translation of principles across industries has opened the door for biomaterials to heal the planet. In this article we showcase creative interpretations of a biomaterial and their range of potential applications in a strive towards more sustainable products. 

Author

June 12, 2024

Senior Care
Startup Spotlight

Forge Genetics: Cutting through the genetic engineering patent thicket.

Companies looking to get innovative biology to patients around the world need to be aware that it takes a 360-degree view of the intellectual property requirements, and in the case of CRISPR this landscape is becoming more and more convoluted, with companies scrambling to renegotiate licensing laws for GMOs to use in research and industry. Taken together, this points towards an opportunity for Forge Genetics to position themselves perfectly, to create a novel, gold-standard gene-editing technology, supporting innovation throughout the global biotechnology industry.

Author

Aonghus Topham

May 29, 2024

Senior Care
Sector Insight

Revolutionizing NMR Access: The Bruker BioSpin Connexus Platform

In the ever-evolving landscape of scientificresearch, access to cutting-edge technologies and expertise is pivotal forbreakthrough discoveries. Among the array of analytical techniques, NuclearMagnetic Resonance (NMR) stands out for its ability to provide detailedinsights into the structure, dynamics, and interactions of molecules. However,the challenge lies in accessing NMR instruments and specialized analyticalservices, particularly for researchers and institutions with limited resourcesor in-house expertise.Bruker BioSpin, a pioneering leader inanalytical magnetic resonance instrumentation, has introduced an innovativesolution: Connexus. Connexus serves as adigital bridge, connecting NMR scientists with laboratories equipped withstate-of-the-art instruments and expertise.

Author

Tobias Wingbermühle

May 15, 2024

Senior Care
Startup Spotlight

Pentabind: AI Enhanced Aptamers Redefining Drug Discovery

PentaBind, a biotech start-up from London, aims to drug the undruggable, targeting diseases that have long been considered beyond the reach of conventional drug discovery methods. Recognising that only 15% of the human proteome has been effectively targeted by existing drugs [2], they are pioneering a novel therapeutic approach that combines the high specificity of aptamers with the power of artificial intelligence (AI).

Author

Giovanni Maresca di Serrapriola

March 14, 2024

Senior Care
Startup Spotlight

BioMavericks: Pioneering Cancer Diagnosis with Next-Generation Sequencing Technology

In the quest to revolutionise cancer diagnosis, BioMavericks emerged amidst the COVID-19 crisis, recognizing a crucial gap in advanced sequencing methods for cancer detection. Their ground-breaking in vitro diagnostic tool, fuelled by proprietary biomarkers, with a sensitivity and specificity of over 97% promises exceptional accuracy in detecting prevalent cancers.

Author

George William Ssendagala

March 6, 2024

Senior Care
Startup Spotlight

Microneedle Solutions (MNS): Improving the needle-free delivery of vaccines

Microneedle Solutions (MNS) is on a quest to increase vaccines uptake by manufacturing affordable self-adhesive vaccine patches that patients can use themselves. The self-administration means that, ultimately, MNS’s product can reduce the strain on healthcare systems and increase vaccine uptake, thus reducing health inequality whilst improving access to vaccines globally.

Author

Ana Ivanus

January 31, 2024

Senior Care
Startup Spotlight

Meet Pear Bio: Revolutionising the way cancer treatments are assigned to patients

Pear Bio is revolutionising the way cancer treatments are assigned to patients. They have developed a functional precision medicine platform by integrating tissue engineering, confocal microscopy, and computer vision into a single patient stratification tool. This facilitates the assessment of the treatment efficacy in the human tumour microenvironment by modelling the impact a drug or a combination of drugs has on the progression of disease.

Author

December 4, 2023

Senior Care
Startup Spotlight

Meet Eden Bio: Pioneering the Biomanufacturing Revolution with AI and High-Throughput Engineering

The biomanufacturing industry is currently experiencing a ground-breaking transformation driven by the integration of AI and new technologies that make high-throughput engineering possible. This paradigm shift has not only pushed the boundaries of biological capabilities, but has also prompted several companies to challenge traditional biomanufacturing methods. Among them, Eden Bio stands out with its bold ambition to redesign and optimise the process for unprecedented efficiency.

Author

October 24, 2023

Sorry we couldn't find anything that matched.
Try adjusting your search terms.

Our latest updates. In your inbox. Once a month.

Sign up for our monthly newsletter of upcoming events, recently published insights and SEC updates.